By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The Ontario Genomics Institute has invested C$100,000 (US$101,000) in Toronto-based molecular diagnostics developer Rna Diagnostics to support further development of the company's lead test for chemotherapy management.

OGI provided the funding to Rna Diagnostics, which has its research lab in Sudbury, Ontario and uses technology developed at Sudbury's Laurentian University, through its Pre-Commercialization Business Development Fund.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.